METformin in DIastolic Dysfunction of MEtabolic Syndrome (MET-DIME) Trial: Rationale and Study Design: MET-DIME Trial

Author： Ladeiras-Lopes Ricardo   Fontes-Carvalho Ricardo   Bettencourt Nuno   Sampaio Francisco   Gama Vasco   Leite-Moreira Adelino  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.28, Iss.2, 2014-04, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial: Rationale and Study Design

By Goette Andreas  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 697-705

Adis International

Access to resources Recommend Favorite

Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: a Randomized, Double-blind Clinical Trial

By Derosa G   Gaddi AV   Ciccarelli L   Fogari E   Ghelfi M   Cicero AFG  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 284-294

Field House Publishing

Access to resources Recommend Favorite

Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial

By Nicholls Stephen   Cavender Matthew   Kastelein John   Schwartz Gregory   Waters David   Rosenson Robert   Bash Dianna   Hislop Colin  

Cardiovascular Drugs and Therapy, Vol. 26, Iss. 1, 2012-02 ,pp. : 71-75

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer

By Kang Yoon-Koo   Muro Kei   Ryu Min-Hee   Yasui Hirofumi   Nishina Tomohiro   Ryoo Baek-Yeol   Kamiya Yukimasa   Akinaga Shiro   Boku Narikazu  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 355-361

Springer Publishing Company

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

By García-González Martín   Mora-Martín Manuel   López-Fernández Silvia   López-Díaz Javier   Martínez-Sellés Manuel   Romero-García José   Cordero Marco   Lara-Padrón Antonio   Marrero-Rodríguez Francisco   Mar García-Saiz M.   Aldea-Perona Ana  

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 573-579

Springer Publishing Company

Access to resources Recommend Favorite